Rafael Holdings Inc (RFL) ニュース

Form DEF 14A - Other definitive proxy statements

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

NEWARK, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its...

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Kuehn Law Encourages CDE, SMC, COFS, and RFL Investors to Contact Law Firm

Kuehn Law Encourages CDE, SMC, COFS, and RFL Investors to Contact Law Firm PR Newswire NEW YORK, Oct. 7, 2024...

Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm

Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm PR Newswire NEW YORK, Sept. 27...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm

Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm PR Newswire NEW YORK, Sept. 23...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement

Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal...

Form 3 - Initial statement of beneficial ownership of securities